Oral Lichen Planus (OLP) is a chronic inflammatory disease with cell-mediated immunopathologic response. Although OLP has been studied extensively for decades, its exactaetiologyremains unclear. Autoimmunity, viruses like Hepatitis C Virus (HCV), Human Papillomavirus (HPV), and stress have all beenhypothesized in recent articles. HPVs are epitheliotropic an affinity keratinocytes principally fo...

Oral lichen planus (OLP) is a chronic mucocutaneous disease with an unknown aetiology, affecting 0.5-2% of the population and with a predilection for females in fourth to fifth decade of life. Most oral lichen planus lesions are asymptomatic but the atrophic and erosive forms of OLP can cause symptoms ranging from spontaneous soreness to severe pain interfering with eating, speech and swallowin...

Sir, oral mucosal as well as skin lesions had a good response. One patient with oral mucosal lesions along with generalized skin Lichen planus is usually a benign and self-limiting disease but in some patients the disease may be severe and unremitting, involvement had a poor response (40%) to the therapy. This patient took the drug for 3 months only and did not report requiring therapeutic inte...

Lichen planus is an inflammatory mucocutaneous disorder. Skin, oral and genital mucosal surfaces, scalp, and nails can be affected. Its development is chronic, with a possible malignant degeneration. Spontaneous remission is rare. Although the etiology of oral lichen planus is still unclear, there is evidence that it is a complex immunologic disease mediated by cytotoxic cells directed against ...

Since its original description by Devergie in 1854, several cases of linear lichen planus have been described in the literature, but there have been notably few cases of the more rare zosteriform lichen planus. Zosteriform lichen planus needs to be differentiated from linear lichen planus and other linear dermatoses. We present a case of Zosteriform Lichen planus for its rarity and briefly revi...

the purpose of this study was to compare the efficacy of retinoic acid 0.05% with triamcinolone acetonide 0.1%, both in an oral base, in the treatment of atrophic and erosive oral lichen planus. thirty patients with clinically proven oral lichen planus were asked to participate in the study. the severity of lesions was scored from 0 (no lesion) to 5 (large erosion), and symptoms were scored ran...

Palmoplantar lichen planus is a localized and uncommon variant of lichen planus which is mostly resistant to treatment. Our purpose was to discuss all treatment modalities proposed and tested for palmoplantar lichen planus in the literature. A systematic review of the literature was conducted to evaluate evidence regarding all treatment modalities proposed and tested for palmoplantar lichen pla...